Latest News
Iovance Surges 12.5% But Price Targets Trail Rally
Iovance shares surged 12.5% to $8.99, setting a new 52-week high, but analyst price targets remain mixed. Q2 revenue jumped 66% to $99.3 million, driven by Amtagvi.
Evergrande Founder Jailed for Life; Vanke Shares Rally
Evergrande founder Hui Ka Yan gets life sentence, assets seized. Vanke shares rise 3.17% despite weak fundamentals; recovery for creditors estimated at 0.57%.
Nokia's China Exit: 1.75-Year Payback, Stock Needs 139% Gain
Nokia's China exit costs €350M, saving €200M annually (1.75-year payback). Shares need 139% gain to justify. Analysts see 48% upside.
NANO Nuclear Declines 5.9% as Cash Pile Overshadows Revenue
NANO Nuclear shares dropped 5.9% to $18.02, as the market weighs a $580M cash cushion against minimal revenue and high valuation multiples.
Corus Restructuring Plan Raises Stakes as TSX Halts Trading
Corus Entertainment announced more job cuts while proposing a C$500M debt reduction that would dilute current shareholders to 1% of the recapitalized company.
Arm's 20% Upside Hinges on AGI CPU Execution Amid 257x P/E
Arm closed at $250.72, up 0.55%, but a 257x trailing P/E and a $350 analyst target range highlight the execution hurdle for its AGI CPU opportunity.
Canaan Soars 13% as Trump Backs Crypto Bill, Treasury Now 72% of Value
Canaan shares surged 13% after President Trump pushed for crypto legislation. The company's digital asset holdings now represent 72% of its market value.
CXMT Stock Surges 565% Post-IPO, Analysts See Limited Upside
CXMT's stock has rocketed 565% since its July IPO, yet analysts project just 10% further upside amid valuation worries and potential DRAM price declines.
AMD's $650 Price Target: A $302B Valuation Hurdle
Roth MKM raises AMD's price target to $650, implying $302 billion in added value, but shares slipped 0.43% as investors await execution proof.
ASML's $49B Plunge Sparks Valuation Concerns Amid Strong Demand Outlook
ASML's market value dropped €45B in three sessions, echoing its 2026 sales forecast. Despite strong AI-driven demand, high valuation and bond yields weigh.